Literature DB >> 20058856

Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites.

Nathanaël Weill1, Didier Rognan.   

Abstract

Inferring the biological function of a protein from its three-dimensional structure as well as explaining why a drug may bind to various targets is of crucial importance to modern drug discovery. Here we present a generic 4833-integer vector describing druggable protein-ligand binding sites that can be applied to any protein and any binding cavity. The fingerprint registers counts of pharmacophoric triplets from the Calpha atomic coordinates of binding-site-lining residues. Starting from a customized data set of diverse protein-ligand binding site pairs, the most appropriate metric and a similarity threshold could be defined for similar binding sites. The method (FuzCav) has been used in various scenarios: (i) screening a collection of 6000 binding sites for similarity to different queries; (ii) classifying protein families (serine endopeptidases, protein kinases) by binding site diversity; (iii) discriminating adenine-binding cavities from decoys. The fingerprint generation and comparison supports ultra-high throughput (ca. 1000 measures/s), does not require prior alignment of protein binding sites, and is able to detect local similarity among subpockets. It is thus particularly well suited to the functional annotation of novel genomic structures with low sequence identity to known X-ray templates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20058856     DOI: 10.1021/ci900349y

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  25 in total

1.  PESDserv: a server for high-throughput comparison of protein binding site surfaces.

Authors:  Sourav Das; Michael P Krein; Curt M Breneman
Journal:  Bioinformatics       Date:  2010-06-10       Impact factor: 6.937

2.  Proteochemometric modeling of the antigen-antibody interaction: new fingerprints for antigen, antibody and epitope-paratope interaction.

Authors:  Tianyi Qiu; Han Xiao; Qingchen Zhang; Jingxuan Qiu; Yiyan Yang; Dingfeng Wu; Zhiwei Cao; Ruixin Zhu
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

3.  A benchmark driven guide to binding site comparison: An exhaustive evaluation using tailor-made data sets (ProSPECCTs).

Authors:  Christiane Ehrt; Tobias Brinkjost; Oliver Koch
Journal:  PLoS Comput Biol       Date:  2018-11-08       Impact factor: 4.475

4.  Binding site characterization - similarity, promiscuity, and druggability.

Authors:  Christiane Ehrt; Tobias Brinkjost; Oliver Koch
Journal:  Medchemcomm       Date:  2019-06-06       Impact factor: 3.597

5.  Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach.

Authors:  Zheng Zhao; Li Xie; Lei Xie; Philip E Bourne
Journal:  J Med Chem       Date:  2016-03-17       Impact factor: 7.446

6.  Updates to Binding MOAD (Mother of All Databases): Polypharmacology Tools and Their Utility in Drug Repurposing.

Authors:  Richard D Smith; Jordan J Clark; Aqeel Ahmed; Zachary J Orban; James B Dunbar; Heather A Carlson
Journal:  J Mol Biol       Date:  2019-05-22       Impact factor: 5.469

7.  Surface-based protein binding pocket similarity.

Authors:  Russell Spitzer; Ann E Cleves; Ajay N Jain
Journal:  Proteins       Date:  2011-07-18

8.  AlphaSpace 2.0: Representing Concave Biomolecular Surfaces Using β-Clusters.

Authors:  Joseph Katigbak; Haotian Li; David Rooklin; Yingkai Zhang
Journal:  J Chem Inf Model       Date:  2020-02-11       Impact factor: 4.956

9.  Structural insights into binding of small molecule inhibitors to Enhancer of Zeste Homolog 2.

Authors:  Marko Kalinić; Mire Zloh; Slavica Erić
Journal:  J Comput Aided Mol Des       Date:  2014-08-20       Impact factor: 3.686

10.  Computational chemogenomics: is it more than inductive transfer?

Authors:  J B Brown; Yasushi Okuno; Gilles Marcou; Alexandre Varnek; Dragos Horvath
Journal:  J Comput Aided Mol Des       Date:  2014-04-27       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.